Yield10 Bioscience Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Yield10 Bioscience Inc (YTEN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Peer Data As of Q2 2024
Competitors Tracked
-
Peer Group Market Share
100.00 %
Revenue Growth Y/Y
-
Net Margin
-719.56 %
Key Findings: Yield10 Bioscience Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 0M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+262.9% annualized vs trailing 12 months).
- Peer revenue share: Yield10 Bioscience Inc accounted for 100.0% of combined revenue among its tracked peer group.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
YTEN Sales vs. its Competitors, Q2 2024
Yield10 Bioscience Inc generated 100.00 % of the combined sales of its peer group.
YTEN Stock Performance relative to its Competitors
YTEN
Competitors (weighted)
Percent change over the selected range
Yield10 Bioscience Inc's Comment on Competition and Industry Peers
Camelina is being developed in North America as a non-food oilseed crop for biofuels such as renewable diesel and sustainable aviation fuel. Oilseed crushers and energy companies are increasing demand for low carbon intensity feedstock oil. Camelina can be grown as a spring rotation crop and as a winter cover crop, enabling two oil harvests per acre each year.